rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1996-9-30
|
pubmed:abstractText |
Hepatitis C virus infection is common in organ transplant recipients, and can be associated with significant morbidity and mortality. A unique feature of this infection among immunosuppressed patients is that it can progress without the development of hepatitis C virus antibodies.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1053-2498
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
865-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8800721-Adult,
pubmed-meshheading:8800721-Female,
pubmed-meshheading:8800721-Heart Transplantation,
pubmed-meshheading:8800721-Hepacivirus,
pubmed-meshheading:8800721-Hepatitis C,
pubmed-meshheading:8800721-Hepatitis C Antibodies,
pubmed-meshheading:8800721-Humans,
pubmed-meshheading:8800721-Immunoblotting,
pubmed-meshheading:8800721-Polymerase Chain Reaction,
pubmed-meshheading:8800721-RNA, Viral,
pubmed-meshheading:8800721-Tissue Donors
|
pubmed:articleTitle |
Prevalence and outcome of hepatitis C infection among heart transplant recipients.
|
pubmed:affiliation |
Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minn, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|